Eating on GLP-1 · Article
Food Tastes Different on Ozempic, Wegovy or Zepbound: Taste, Smell, Coffee and Meat Aversions
What US labels and studies say about taste and smell changes on semaglutide and tirzepatide, and what to eat when coffee, meat or eggs lose their appeal.
- Written by
- Alex Gonzalez
- Published
- Next review
- Sources
- 13 primary and 9 supporting
No clinical review. No advertising from drug companies and no affiliate links.How we work
On semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro), altered taste is in the FDA labels, but it’s uncommon: in the three labels that give a figure, between 0.1% and 1.7% of trial participants reported it134, and Ozempic’s says only that it was above 0.4%[2]. None of the four labels mentions smell. The handful of taste studies point in opposite directions, and specific aversions, like suddenly not tolerating coffee or meat, have barely been studied. Here I separate what’s measured from what’s reported, and cover what to eat so protein doesn’t fall through the cracks.
The short version
- Labels: dysgeusia (altered taste) in 1.7% on Wegovy versus 0.5% on placebo, and 0.4% on Zepbound versus none13.
- Studies: a trial in 30 women found semaglutide improved taste recognition[5]; a study of 46 users found worse taste scores[8].
- Aversions: described, sometimes severe, mostly when starting treatment and with dose increases[16].
- What to do: if meat, eggs or coffee stop appealing, dairy, seafood, poultry and beans still cover protein.
I use “taste” for what the tongue detects and “flavor” for taste plus smell. The distinction matters: according to the NIDCD, the NIH institute that studies these senses, most people who think they’ve lost their sense of taste actually have a smell problem[17]. Sweet cravings have their own page, sweet cravings on Ozempic or Mounjaro, and so does nausea.
What the FDA labels say about taste
| Medication | What the label reports |
|---|---|
| Wegovy (semaglutide, weight) | Dysgeusia in 1.7% of patients versus 0.5% on placebo in adult weight-reduction trials[1] |
| Ozempic (semaglutide, type 2 diabetes) | Dysgeusia listed with fatigue and dizziness among other adverse reactions with a frequency above 0.4%[2] |
| Zepbound (tirzepatide, weight) | Dysgeusia in 0.4% of patients versus none on placebo[3] |
| Mounjaro (tirzepatide, type 2 diabetes) | Dysgeusia in 0.1% of patients versus 0% on placebo[4] |
What the labels don’t say:
- Nothing about smell. I found no mention of smell in any of the four labels1234.
- Nothing about specific foods. The labels say the drugs decrease calorie intake, likely by affecting appetite13, but not what happens to coffee or steak.
- How long it lasts. None of them gives a duration.
The Zepbound label also lists dry mouth or dry throat in 1% versus 0.1% on placebo[3], and dry mouth can change how food tastes, according to the National Cancer Institute[20].
What studies measured on taste
I found four studies in people that measure taste or smell. They don’t agree:
| Study | Who and how long | What it found |
|---|---|---|
| Jensterle, 2025[5] | 30 women with obesity and polycystic ovary syndrome; semaglutide 1 mg or placebo (single-blind); 16 weeks | Better taste recognition: from 11.9 to 14.4 points out of 16. Changes in tongue genes and in brain responses to sweet taste |
| Brindisi, 2019[7] | 18 people with type 2 diabetes; liraglutide; 3 months; no control group | Detected sweetness at lower concentrations and wanted sweet foods less |
| Khan and Doty, 2025[8] | 46 GLP-1 users versus 46 matched controls; tested once | Lower scores for all five basic tastes; smell not significantly different |
| Zontag, 2026[9] | Health records of 438,474 people with type 2 diabetes on a GLP-1 and as many on other diabetes drugs | More diagnosed smell disorders (hazard ratio 1.81) and taste disorders (1.52) |
How I read them:
- Only the first has a placebo group, and it’s small and in a narrow group. It’s the study presented at the Endocrine Society’s ENDO 2024 meeting[6].
- Khan and Doty can’t tell what taste was like before treatment. One author heads the company that makes the tests used, and says so[8].
- Zontag counts diagnoses, not measured symptoms, in people with diabetes, and the abstract doesn’t break results down by drug[9].
- FDA adverse event reports show signals for dysgeusia and parosmia (distorted smells) across GLP-1 drugs[10], and for anosmia (loss of smell) with semaglutide[11]. These are associations, not causes[10].
Animal data doesn’t settle it either. Mice without the GLP-1 receptor responded less to sweet taste[12]. But in obese mice given semaglutide long term, taste didn’t change, and the authors point to motivation to eat rather than the tongue[13].
Smell and aversions: meat, coffee, fried food and alcohol
The 2025 nutrition advisory on GLP-1 therapy from four US societies says some people report food aversions, sometimes severe, typically when starting treatment and with dose increases, and that anecdotal reports suggest less enjoyment of taste[16].
| What people report | Studied? | What there is |
|---|---|---|
| A stronger sense of smell | Not as such | I found no study measuring a “sharper” sense of smell. One found no significant difference[8]; another, more diagnosed smell disorders[9] |
| Meat is a turn-off | No | I found no GLP-1 studies. In cancer treatment, meat can taste bitter or metallic, says the National Cancer Institute[20] |
| Fried and fatty food | Partly | The 2025 advisory says the evidence supports a general shift away from sweet, savory, starchy and high-fat foods[16] |
| Coffee lost its appeal | No | I found no studies and nothing in the labels: reports, not data |
| Less interest in alcohol | Yes, in one small trial | In 48 adults with alcohol use disorder, low-dose semaglutide reduced alcohol drunk in a lab session and weekly craving[21]. More in alcohol and GLP-1 |
Why it might happen: hypotheses, not answers
None of these explanations is proven in people:
- Nausea and learned aversion. If a food lines up with feeling sick, the brain can learn to reject it. In a 1978 study, children who ate an unusual ice cream before chemotherapy that upset their stomach were less likely to choose it again[15]. That fits aversions clustering around dose increases[16]. In mice, activating the GIP receptor, tirzepatide’s second target, reduced learned taste avoidance[14]; that says nothing yet about Zepbound in people.
- Slower stomach emptying. Semaglutide delays gastric emptying, says the Wegovy label[1]. For tirzepatide, the delay is largest after the first dose and this effect diminishes over time[3]. A fatty meal that sits heavy can end up linked to rejection.
- Reward changes. In the Jensterle trial, brain responses to food pictures and sweet taste changed[5], and the mouse study points to motivation rather than the tongue[13]. If food “pulls” less, an old favorite can become indifferent.
- Changes in the tongue itself. GLP-1 is present in mouse taste cells[12], and the Jensterle trial found gene changes in tongue tissue[5]. What that means for your morning coffee, nobody knows yet.
What to eat when coffee, meat or eggs lose their appeal
The 2025 advisory warns that getting enough protein can be hard because of low appetite or taste aversions. It suggests eating the protein-rich food first, and lists beans, peas and lentils, dairy, seafood, eggs and lean poultry as sources to favor[16]. If one falls off, the others are still there:
| If you’ve gone off… | Try | Serving | Protein | Calories |
|---|---|---|---|---|
| Red meat | Turkey breast | 100 g raw (3.5 oz) | 23.7 g | 114 kcal |
| Red meat | Shrimp, cooked | 100 g (3.5 oz) | 22.8 g | 119 kcal |
| Meat in general | Lentils, cooked | 150 g (about ¾ cup) | 13.5 g | 174 kcal |
| Meat in general | Firm tofu | 100 g (3.5 oz) | 9.0 g | 78 kcal |
| Eggs | Plain nonfat skyr | 150 g (5.3 oz) | 17.0 g | 90 kcal |
| Eggs | Cottage cheese, 2% | 100 g (about ½ cup) | 10.4 g | 81 kcal |
| Coffee with milk | Reduced-fat milk, 2% | 250 ml (about 1 cup) | 8.3 g | 125 kcal |
| Cooking smells | Shredded cooked chicken, cold | 80 g (2.8 oz) | 23.2 g | 121 kcal |
Data: USDA FoodData Central[22], on each food page. Set your own target with the protein calculator. If meat has dropped off your plate entirely, there’s more in plant protein on GLP-1 medications.
Tricks for odd tastes and strong smells
These come from the National Cancer Institute’s guidance on taste changes during cancer treatment[20]. Nobody has tested them with GLP-1 drugs, but they target the same practical problem:
- If red meat tastes metallic, try chicken, turkey, dairy, tofu or beans, and plastic or wooden utensils.
- If everything tastes flat, marinate meat overnight in the fridge and use herbs, spices, vinegar or citrus.
- If smells bother you, keep food covered until serving, drink from cups with lids and straws, and run the kitchen fan.
- If cooking is the problem, go for no-cook foods: protein shakes, Greek yogurt parfaits, a sandwich.
The nausea guide makes a similar point: cold or bland dishes and fewer smells. For more ideas: high-protein shakes without powder, high-protein breakfasts for a small appetite, batch cooking for a small appetite, the 7-day meal plan and the weekly menu planner.
If coffee is off the table
Nothing says you have to keep drinking it. But if it was a big part of your daily fluids, replace that liquid with water, tea, milk or broth. I cover it in hydration on GLP-1 medications, with a hydration calculator.
Food losing its pull can go hand in hand with quieter food noise, the intrusive thoughts about eating. The catch is not to mistake less noise for eating too little.
When it matters: eating less than you need
The 2025 advisory spells out the risk: with little interest in food, some people go hours without eating and fall short on nutrients, and losing the pleasure of eating can lead some to stop treatment[16]. The NIDCD adds that when taste or smell is impaired, some people eat too little, while others add extra salt or sugar1718.
Signs the change is costing you:
- You skip meals because nothing appeals.
- You fall well short of your protein number several days in a row.
- You’re full after two bites: see early satiety.
- Or you’re hungry, but nothing sounds good: see still hungry on Ozempic or Mounjaro.
Log it in the symptom diary and bring it to your appointment. The advisory suggests talking it through, considering behavioral therapy and, for some people, a change in dose or medication[16], a decision for your prescriber. If you’ve been eating little for weeks, also read vitamins and minerals when eating little.
When to call your doctor
When to call your doctor
- Nausea, vomiting or diarrhea that won’t go away, or you can’t keep fluids down. The Wegovy and Zepbound Medication Guides warn that diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems, and to tell your provider right away if they don’t go away13.
- Severe stomach pain that won’t go away, with or without vomiting, sometimes reaching your back. Both Medication Guides list it as a possible sign of pancreatitis that needs a call to your provider right away13.
- You use insulin or a sulfonylurea and you’re eating much less. Per the Zepbound label, concomitant use with insulin or an insulin secretagogue may increase the risk of hypoglycemia, including severe hypoglycemia[3].
- The taste change doesn’t go away or comes with other symptoms. That’s MedlinePlus’s threshold for contacting a provider; it lists other causes such as colds, sinus infections, dry mouth, low vitamin B12 or zinc, and other medicines[19].
- You lose your sense of smell. Smell warns you of smoke, gas leaks and spoiled food, and a smell disorder can be an early sign of other conditions; an ear, nose and throat specialist evaluates it[18].
- Food has become a source of distress, or you find yourself trying to eat as little as possible. Ask for professional help.
FAQ
Is it normal for food to taste different on Ozempic or Zepbound?
It happens, but it isn’t common. In the labels that give a figure, between 0.1% and 1.7% of trial participants reported altered taste134. The 2025 advisory also describes food aversions, sometimes severe, which none of the labels lists[16].
Does taste go back to normal?
I found no study that has tracked it. The 2025 advisory places aversions mostly at the start of treatment and around dose increases[16], and none of the labels gives a duration1234. If it doesn’t improve, bring it up with your prescriber.
Why can’t I stand coffee anymore?
I found no study on it. The leading ideas are a learned aversion if coffee lined up with nausea[15], reward changes in the brain513 and altered taste or smell89. If you drop it, replace the fluid with something else.
Can I stop eating meat on Wegovy or Zepbound?
Yes, as long as protein comes from somewhere else. The 2025 advisory lists beans, peas and lentils, dairy, seafood, eggs and poultry as sources to favor[16]. A 150 g (5.3 oz) cup of skyr plus 150 g of cooked lentils gives you 30.5 g of protein[22]. More ideas are in plant protein on GLP-1 medications.
Sources
Sources consulted for this article, with the access date.
- Drug labelU.S. Food and Drug Administration (DailyMed, NIH).WEGOVY (semaglutide): prescribing information (sections 6.1 and 12.2) and Medication Guide, revised June 2026.accessed .
- Drug labelU.S. Food and Drug Administration (DailyMed, NIH).OZEMPIC (semaglutide): prescribing information, section 6.1, revised June 2026.accessed .
- Drug labelU.S. Food and Drug Administration (DailyMed, NIH).ZEPBOUND (tirzepatide): prescribing information (sections 5, 6.1 and 12.2) and Medication Guide, revised August 2026.accessed .
- Drug labelU.S. Food and Drug Administration (DailyMed, NIH).MOUNJARO (tirzepatide): prescribing information, section 6.1, revised August 2026.accessed .
- Clinical trialThe Journal of Clinical Endocrinology & Metabolism (Endocrine Society).Jensterle M, Kovac J, Vovk A, et al. Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study. J Clin Endocrinol Metab. 2025;111(1):e270-e280. doi:10.1210/clinem/dgaf278.accessed .
- InstitutionEndocrine Society.GLP-1 has the power to change taste sensitivity in women with obesity (ENDO 2024 press release, June 1, 2024).accessed .
- Other sourceDiabetes & Metabolic Syndrome: Clinical Research & Reviews (Elsevier).Brindisi MC, Brondel L, Meillon S, et al. Proof of concept: Effect of GLP-1 agonist on food hedonic responses and taste sensitivity in poor controlled type 2 diabetic patients. Diabetes Metab Syndr. 2019;13(4):2489-2494. doi:10.1016/j.dsx.2019.06.021.accessed .
- Other sourcePhysiology & Behavior (Elsevier).Khan R, Doty RL. GLP-1 receptor agonists significantly impair taste function. Physiol Behav. 2025;291:114793. doi:10.1016/j.physbeh.2024.114793.accessed .
- Other sourceJAMA Otolaryngology–Head & Neck Surgery.Zontag J, Zontag N. Smell and Taste Disturbances Among Glucagon-Like Peptide-1 Receptor Agonist Users. JAMA Otolaryngol Head Neck Surg. 2026;152(8):758-765. doi:10.1001/jamaoto.2026.1498.accessed .
- Other sourceScientific Reports (Springer Nature).Chen H, Liu S, Gao S, et al. Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System. Sci Rep. 2025;15(1):18063. doi:10.1038/s41598-025-01206-9.accessed .
- Other sourceThe Laryngoscope (Wiley).Khan FI, Vazquez SG, Mehdi Z, et al. Otolaryngologic Side Effects of GLP-1 Receptor Agonists. Laryngoscope. 2025;135(7):2291-2298. doi:10.1002/lary.32061.accessed .
- Other sourceThe FASEB Journal.Takai S, Yasumatsu K, Inoue M, et al. Glucagon-like peptide-1 is specifically involved in sweet taste transmission. FASEB J. 2015;29(6):2268-2280. doi:10.1096/fj.14-265355.accessed .
- Other sourceMolecular Metabolism (Elsevier).Acosta AA, Ellis H, Hsu FY, et al. Chronic semaglutide alters ingestive behavior without impairing taste function in mice. Mol Metab. 2026;110:102410. doi:10.1016/j.molmet.2026.102410.accessed .
- Other sourceMolecular Metabolism (Elsevier).Costa A, Ai M, Nunn N, et al. Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation. Mol Metab. 2022;55:101407. doi:10.1016/j.molmet.2021.101407.accessed .
- Other sourceScience (AAAS).Bernstein IL. Learned taste aversions in children receiving chemotherapy. Science. 1978;200(4347):1302-1303. doi:10.1126/science.663613.accessed .
- Clinical guidelineObesity (The Obesity Society, Wiley).Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity. 2025;33(8):1475-1503. doi:10.1002/oby.24336.accessed .
- InstitutionNational Institute on Deafness and Other Communication Disorders (NIDCD, NIH).Taste Disorders.accessed .
- InstitutionNational Institute on Deafness and Other Communication Disorders (NIDCD, NIH).Smell Disorders.accessed .
- InstitutionMedlinePlus, U.S. National Library of Medicine (NIH).Taste - impaired (medical encyclopedia, reviewed January 29, 2025).accessed .
- InstitutionNational Cancer Institute (NIH).Nutrition During Cancer (section on taste and smell changes).accessed .
- Clinical trialJAMA Psychiatry.Hendershot CS, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82(4):395-405. doi:10.1001/jamapsychiatry.2024.4789.accessed .
- Official databaseU.S. Department of Agriculture, Agricultural Research Service.FoodData Central (per-100 g values for each food cited in the /en/foods/ food pages).accessed .